Podofilox, epirubicin and dexrazoxane are DNA topoisomerase 2-alpha (TOP2A) inhibitors and are proposed by the current analysis for treating advanced-stage MCL (BcelltoMCL). The gene discussed is TOP2A; the disease is mantle cell lymphoma.